Dietary Oxalate Intake and Kidney Outcomes

Holmes, 2001, Contribution of dietary oxalate to urinary oxalate excretion, Kidney Int., 59, 270, 10.1046/j.1523-1755.2001.00488.x

Coe, 2005, Kidney stone disease, J. Clin. Investig., 115, 2598, 10.1172/JCI26662

Hatch, 1994, Intestinal excretion of oxalate in chronic renal failure, J. Am. Soc. Nephrol., 5, 1339, 10.1681/ASN.V561339

Costello, 1992, Extrarenal clearance of oxalate increases with progression of renal failure in the rat, J. Am. Soc. Nephrol., 3, 1098, 10.1681/ASN.V351098

Hatch, 2003, Angiotensin II involvement in adaptive enteric oxalate excretion in rats with chronic renal failure induced by hyperoxaluria, Urol. Res., 31, 426, 10.1007/s00240-003-0367-5

Lange, J.N., Wood, K.D., Knight, J., Assimos, D.G., and Holmes, R.P. (2020, August 17). Glyoxal Formation and Its Role in Endogenous Oxalate Synthesis. Available online: https://www.hindawi.com/journals/au/2012/819202/.

Knight, 2006, Hydroxyproline ingestion and urinary oxalate and glycolate excretion, Kidney Int., 70, 1929, 10.1038/sj.ki.5001906

Holmes, 2016, Lowering urinary oxalate excretion to decrease calcium oxalate stone disease, Urolithiasis, 44, 27, 10.1007/s00240-015-0839-4

Israr, 2013, Effects of phytate and minerals on the bioavailability of oxalate from food, Food Chem., 141, 1690, 10.1016/j.foodchem.2013.04.130

Worcester, 2002, Stones from bowel disease, Endocrinol. Metab. Clin. N. Am., 31, 979, 10.1016/S0889-8529(02)00035-X

Ticinesi, 2019, Gut microbiome and kidney stone disease: Not just an Oxalobacter story, Kidney Int., 96, 25, 10.1016/j.kint.2019.03.020

Marques, 2017, A case of oxalate nephropathy: When a single cause is not crystal clear, Am. J. Kidney Dis., 70, 722, 10.1053/j.ajkd.2017.05.022

Waikar, 2019, Association of urinary oxalate excretion with the risk of chronic kidney disease progression, JAMA Intern. Med., 179, 542, 10.1001/jamainternmed.2018.7980

Cuvelier, 2002, Enteric hyperoxaluria: A hidden cause of early renal graft failure in two successive transplants: Spontaneous late graft recovery, Am. J. Kidney Dis., 40, e3.1, 10.1053/ajkd.2002.33934

Ermer, 2016, Oxalate, inflammasome, and progression of kidney disease, Curr. Opin. Nephrol. Hypertens., 25, 363, 10.1097/MNH.0000000000000229

Hatch, 1993, Characteristics of the transport of oxalate and other ions across rabbit proximal colon, Pflugers Arch., 423, 206, 10.1007/BF00374396

Asplin, 2002, Hyperoxaluric calcium nephrolithiasis, Endocrinol. Metab. Clin. N. Am., 31, 927, 10.1016/S0889-8529(02)00030-0

Whittamore, 2017, The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man, Urolithiasis, 45, 89, 10.1007/s00240-016-0952-z

Chen, 2003, Clinical investigation on gastric oxalate absorption, Chin. Med. J., 116, 1749

Hautmann, 1993, The stomach: A new and powerful oxalate absorption site in man, J. Urol., 149, 1401, 10.1016/S0022-5347(17)36400-5

Knauf, 2011, Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion, J. Am. Soc. Nephrol., 22, 2247, 10.1681/ASN.2011040433

Hatch, 2008, The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis, Semin. Nephrol., 28, 143, 10.1016/j.semnephrol.2008.01.007

Simpson, 2007, PAT-1 (Slc26a6) is the predominant apical membrane Cl− /HCO3− exchanger in the upper villous epithelium of the murine duodenum, Am. J. Physiol. Gastrointest. Liver Physiol., 292, G1079, 10.1152/ajpgi.00354.2006

Wang, 2002, Identification of an apical Cl− /HCO3− exchanger in the small intestine, Am. J. Physiol. Gastrointest. Liver Physiol., 282, G573, 10.1152/ajpgi.00338.2001

Freel, 2006, Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice, Am. J. Physiol. Gastrointest. Liver Physiol., 290, G719, 10.1152/ajpgi.00481.2005

Jiang, 2006, Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6, Nat. Genet., 38, 474, 10.1038/ng1762

Neumeier, L.I., Thomson, R.B., Reichel, M., Eckardt, K.-U., Aronson, P.S., and Knauf, F. (2020). Enteric oxalate secretion mediated by slc26a6 defends against hyperoxalemia in murine models of chronic kidney disease. J. Am. Soc. Nephrol.

Freel, 2013, Transcellular oxalate and Cl− absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate, Am. J. Physiol. Gastrointest. Liver Physiol., 305, G520, 10.1152/ajpgi.00167.2013

Fargue, 2018, Hydroxyproline metabolism and oxalate synthesis in primary hyperoxaluria, JASN, 29, 1615, 10.1681/ASN.2017040390

Robijn, 2011, Hyperoxaluria: A gut–kidney axis?, Kidney Int., 80, 1146, 10.1038/ki.2011.287

Fraser, 2002, Clinical Toxicologic implications of ethylene glycol and glycolic acid poisoning, Ther. Drug Monit., 24, 232, 10.1097/00007691-200204000-00005

Humayun, 2016, Acute oxalate nephropathy associated with orlistat, J. Nephropathol., 5, 79, 10.15171/jnp.2016.14

Urivetzky, 1992, Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis, J. Urol., 147, 1215, 10.1016/S0022-5347(17)37521-3

Osswald, 1979, Renal elimination kinetics and plasma half-life of oxalate in man, Urol. Int., 34, 440, 10.1159/000280294

Williams, 1971, The renal clearance of oxalate in normal subjects and patients with primary hyperoxaluria, Clin. Sci., 41, 213, 10.1042/cs0410213

Bergsland, 2011, Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones, Am. J. Physiol. Ren. Physiol., 300, F311, 10.1152/ajprenal.00411.2010

Holmes, 2005, Dietary oxalate loads and renal oxalate handling, J. Urol., 174, 943, 10.1097/01.ju.0000169476.85935.e2

Samra, 1988, Effect of excretory-secretory products of Giardia lamblia on glucose and phenylalanine transport in the small intestine of Swiss albino mice, Biochem. Int., 17, 801

Hoppe, 2012, An update on primary hyperoxaluria, Nat. Rev. Nephrol., 8, 467, 10.1038/nrneph.2012.113

Bhasin, 2015, Primary and secondary hyperoxaluria: Understanding the enigma, World J. Nephrol., 4, 235, 10.5527/wjn.v4.i2.235

Mykytiv, 2018, Anemia in patient with primary hyperoxaluria and bone marrow involvement by oxalate crystals, Hematol. Oncol. Stem Cell Ther., 11, 118, 10.1016/j.hemonc.2017.07.007

Mookadam, 2010, Cardiac abnormalities in primary hyperoxaluria, Circ. J., 74, 2403, 10.1253/circj.CJ-10-0107

Cochat, 2013, Primary Hyperoxaluria, N. Engl. J. Med., 369, 649, 10.1056/NEJMra1301564

Purdue, 1990, Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1, J. Cell Biol., 111, 2341, 10.1083/jcb.111.6.2341

Milliner, 2001, Phenotypic expression of primary hyperoxaluria: Comparative features of types I and II, Kidney Int., 59, 31, 10.1046/j.1523-1755.2001.00462.x

Monico, 2011, Primary hyperoxaluria type iii gene HOGA1 (Formerly DHDPSL ) as a possible risk factor for idiopathic calcium oxalate urolithiasis, Clin. J. Am. Soc. Nephrol., 6, 2289, 10.2215/CJN.02760311

Harambat, 2012, Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy, Clin. J. Am. Soc. Nephrol., 7, 458, 10.2215/CJN.07430711

Lieske, 2005, International registry for primary hyperoxaluria, Am. J. Nephrol., 25, 290, 10.1159/000086360

Groothoff, 2012, Primary hyperoxaluria Type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: Results of the Dutch cohort, Nephrol. Dial. Transplant., 27, 3855, 10.1093/ndt/gfs320

Bergstralh, 2010, The IPHR investigators transplantation outcomes in primary hyperoxaluria: Transplantation in primary hyperoxaluria, Am. J. Transplant., 10, 2493, 10.1111/j.1600-6143.2010.03271.x

Holmes, 2000, Estimation of the oxalate content of foods and daily oxalate intake, Kidney Int., 57, 1662, 10.1046/j.1523-1755.2000.00010.x

Clark, 2019, Diet-induced oxalate nephropathy, BMJ Case Rep., 12, e231284, 10.1136/bcr-2019-231284

Karaolanis, 2014, Secondary hyperoxaluria: A risk factor for kidney stone formation and renal failure in native kidneys and renal grafts, Transplant. Rev., 28, 182, 10.1016/j.trre.2014.05.004

Nazzal, 2016, Enteric hyperoxaluria: An important cause of end-stage kidney disease, Nephrol. Dial. Transplant., 31, 375, 10.1093/ndt/gfv005

Brown, M.J., Ameer, M.A., and Beier, K. (2020). Vitamin B6 deficiency (Pyridoxine). StatPearls, StatPearls Publishing.

Clements, 2006, Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting, Am. Surg., 72, 1196, 10.1177/000313480607201209

Kohbrok, 2014, Vitamin B6 in primary hyperoxaluria I: First prospective trial after 40 years of practice, Clin. J. Am. Soc. Nephrol., 9, 468, 10.2215/CJN.06820613

Earnest, 1975, A physicochemical basis for treatment of enteric hyperoxaluria, Trans. Assoc. Am. Phys., 88, 224

Barilla, 1978, Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium, Am. J. Med., 64, 579, 10.1016/0002-9343(78)90576-4

Lemann, 1996, Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults, Kidney Int., 49, 200, 10.1038/ki.1996.27

Siener, 2003, Dietary risk factors for hyperoxaluria in calcium oxalate stone formers, Kidney Int., 63, 1037, 10.1046/j.1523-1755.2003.00807.x

Taylor, 2008, Determinants of 24-hour urinary oxalate excretion, Clin. J. Am. Soc. Nephrol., 3, 1453, 10.2215/CJN.01410308

Kumar, 2004, Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: Possible role in renal stone formation, J. Gastroenterol. Hepatol., 19, 1403, 10.1111/j.1440-1746.2004.03510.x

Sidhu, 1999, Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: Possible prevention by gut recolonization or enzyme replacement therapy, J. Am. Soc. Nephrol., 10, S334

Miller, 2019, Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis, Kidney Int., 96, 180, 10.1016/j.kint.2019.02.012

Kharlamb, 2011, Oral antibiotic treatment of helicobacter pylori leads to persistently reduced intestinal colonization rates with oxalobacter formigenes, J. Endourol., 25, 1781, 10.1089/end.2011.0243

Soleimani, 2008, The role of SLC26A6-mediated chloride/oxalate exchange in causing susceptibility to nephrolithiasis, J. Physiol., 586, 1205, 10.1113/jphysiol.2007.150565

Amin, 2018, Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria, Kidney Int., 93, 1098, 10.1016/j.kint.2017.11.011

Kletzmayr, 2020, Investigational therapies for primary hyperoxaluria, Bioconjug. Chem., 31, 1696, 10.1021/acs.bioconjchem.0c00268

Liebow, 2017, An investigational rnai therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria, J. Am. Soc. Nephrol., 28, 494, 10.1681/ASN.2016030338

Zabaleta, 2018, CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I, Nat. Commun., 9, 5454, 10.1038/s41467-018-07827-1

Dutta, 2016, Inhibition of glycolate oxidase with dicer-substrate siRNA Reduces calcium oxalate deposition in a mouse model of primary hyperoxaluria type 1, Mol. Ther., 24, 770, 10.1038/mt.2016.4

Lai, 2018, Specific inhibition of hepatic lactate dehydrogenase reduces oxalate production in mouse models of primary hyperoxaluria, Mol. Ther., 26, 1983, 10.1016/j.ymthe.2018.05.016

Touw, 1986, Acute lymphoblastic leukemia and non-Hodgkin’s lymphoma of T lineage: Colony-forming cells retain growth factor (interleukin 2) dependence, Blood, 68, 1088, 10.1182/blood.V68.5.1088.1088

Sada, 2015, Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy, Science, 347, 1362, 10.1126/science.aaa1299

Huguet, 2019, Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning, J. Clin. Investig., 129, 2571, 10.1172/JCI99822

Milliner, 2018, A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria, Urolithiasis, 46, 313, 10.1007/s00240-017-0998-6

Lingeman, 2019, ALLN-177, oral enzyme therapy for hyperoxaluria, Int. Urol. Nephrol., 51, 601, 10.1007/s11255-019-02098-1

Mitchell, 2019, Dietary oxalate and kidney stone formation, Am. J. Physiol. Ren. Physiol., 316, F409, 10.1152/ajprenal.00373.2018

Heilberg, 2013, Optimum nutrition for kidney stone disease, Adv. Chronic Kidney Dis., 20, 165, 10.1053/j.ackd.2012.12.001

Rathi, 2007, Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: A case report, J. Med. Case Rep., 1, 155, 10.1186/1752-1947-1-155

Ferraro, P.M., Bargagli, M., Trinchieri, A., and Gambaro, G. (2020). Risk of kidney stones: Influence of dietary factors, dietary patterns, and vegetarian vegan diets. Nutrients, 12.

Han, 2015, Nutritional management of kidney stones (Nephrolithiasis), Clin. Nutr. Res., 4, 137, 10.7762/cnr.2015.4.3.137

Pearle, 2014, Medical management of kidney stones: AUA guideline, J. Urol., 192, 316, 10.1016/j.juro.2014.05.006

Curhan, 1993, A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones, N. Engl. J. Med., 328, 833, 10.1056/NEJM199303253281203

Curhan, 1997, Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women, Ann. Intern. Med., 126, 497, 10.7326/0003-4819-126-7-199704010-00001

Borghi, 2002, Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria, N. Engl. J. Med., 346, 77, 10.1056/NEJMoa010369

Ferraro, 2017, Dietary and lifestyle risk factors associated with incident kidney stones in men and women, J. Urol., 198, 858, 10.1016/j.juro.2017.03.124

D’Alessandro, C., Ferraro, P.M., Cianchi, C., Barsotti, M., Gambaro, G., and Cupisti, A. (2019). Which diet for calcium stone patients: A real-world approach to preventive care. Nutrients, 11.

Taylor, 2007, Oxalate intake and the risk for nephrolithiasis, J. Am. Soc. Nephrol., 18, 2198, 10.1681/ASN.2007020219

Curhan, 2008, 24-h uric acid excretion and the risk of kidney stones, Kidney Int., 73, 489, 10.1038/sj.ki.5002708

Takei, 1998, Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria, Urol. Int., 61, 192, 10.1159/000030323

2004, Dependence of oxalate absorption on the daily calcium intake, J. Am. Soc. Nephrol., 15, 1567, 10.1097/01.ASN.0000127864.26968.7F

Martini, 2003, Effects of an oxalate load on urinary oxalate excretion in calcium stone formers, J. Ren. Nutr., 13, 39, 10.1053/jren.2003.50002

Gu, 2010, Oxalate content of green tea of different origin, quality, preparation and time of harvest, Urol. Res., 38, 377, 10.1007/s00240-009-0245-x

Mahdavi, 2013, Effect of different brewing times on soluble oxalate content of loose-packed black teas and tea bags, Urolithiasis, 41, 15, 10.1007/s00240-012-0521-z

Chen, 2018, Does green tea consumption increase urinary oxalate excretion? Results of a prospective trial in healthy men, Int. Urol. Nephrol., 50, 29, 10.1007/s11255-017-1720-x

Hesse, 1999, Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: Application of a new test with [13C2]oxalate, J. Am. Soc. Nephrol., 10, S329

Nguyen, 2001, Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers, Kidney Int., 59, 2273, 10.1046/j.1523-1755.2001.00744.x

Ferraro, 2019, Antibiotic use and risk of incident kidney stones in female nurses, Am. J. Kidney Dis., 74, 736, 10.1053/j.ajkd.2019.06.005

Stern, 2016, Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers, Urolithiasis, 44, 399, 10.1007/s00240-016-0882-9

Liu, 2019, H19 promote calcium oxalate nephrocalcinosis-induced renal tubular epithelial cell injury via a ceRNA pathway, EBioMedicine, 50, 366, 10.1016/j.ebiom.2019.10.059

Albert, 2018, Oral administration of oxalate-enriched spinach extract as an improved methodology for the induction of dietary hyperoxaluric nephrocalcinosis in experimental rats, Toxicol. Mech. Methods, 28, 195, 10.1080/15376516.2017.1388459

Hoppe, 2005, Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis, Am. J. Kidney Dis., 46, 440, 10.1053/j.ajkd.2005.06.003

Kumar, 2020, Dietary oxalate induces urinary nanocrystals in humans, Kidney Int. Rep., 5, 1040, 10.1016/j.ekir.2020.04.029

Knauf, 2013, NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy, Kidney Int., 84, 895, 10.1038/ki.2013.207

Mulay, 2016, Crystallopathies, N. Engl. J. Med., 374, 2465, 10.1056/NEJMra1601611

Buysschaert, B., Aydin, S., Morelle, J., Gillion, V., Jadoul, M., and Demoulin, N. (2020). Etiologies, clinical features, and outcome of oxalate nephropathy. Kidney Int. Rep.

Mulay, 2017, Crystal nephropathies: Mechanisms of crystal-induced kidney injury, Nat. Rev. Nephrol., 13, 226, 10.1038/nrneph.2017.10

Wijayaratne, D.R., Bavanthan, V., de Silva, M.V.C., Nazar, A.L.M., and Wijewickrama, E.S. (2018). Star fruit nephrotoxicity: A case series and literature review. BMC Nephrol., 19.

Chen, 2001, Acute oxalate nephropathy after ingestion of star fruit, Am. J. Kidney Dis., 37, 418, 10.1053/ajkd.2001.21333

Fang, 2008, Mechanisms of star fruit-induced acute renal failure, Food Chem. Toxicol., 46, 1744, 10.1016/j.fct.2008.01.016

Su, 2011, Quiz page April 2011, Am. J. Kidney Dis., 57, A23, 10.1053/j.ajkd.2010.11.023

Park, 2014, Peanut-induced acute oxalate nephropathy with acute kidney injury, Kidney Res. Clin. Pract., 33, 109, 10.1016/j.krcp.2014.03.003

Makkapati, 2018, “Green smoothie cleanse” causing acute oxalate nephropathy, Am. J. Kidney Dis., 71, 281, 10.1053/j.ajkd.2017.08.002

Syed, 2015, A Case of Iced-Tea Nephropathy, N. Engl. J. Med., 372, 1377, 10.1056/NEJMc1414481

Albersmeyer, M., Hilge, R., Schröttle, A., Weiss, M., Sitter, T., and Vielhauer, V. (2012). Acute kidney injury after ingestion of rhubarb: Secondary oxalate nephropathy in a patient with type 1 diabetes. BMC Nephrol., 13.

Lin, 2019, Ascorbic acid-induced oxalate nephropathy: A case report and discussion of pathologic mechanisms, CEN Case Rep., 8, 67, 10.1007/s13730-018-0366-6

Mulay, 2016, Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice, Am. J. Physiol. Ren. Physiol., 310, F785, 10.1152/ajprenal.00488.2015

Wilson, 2018, The role of oxidative stress and inflammation in acute oxalate nephropathy associated with ethylene glycol intoxication, Kidney Int. Rep., 3, 1217, 10.1016/j.ekir.2018.05.005

Mulay, 2013, Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion, J. Clin. Investig., 123, 236, 10.1172/JCI63679

Hoppe, 1999, Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure, Kidney Int., 56, 268, 10.1046/j.1523-1755.1999.00546.x

Ogawa, 2006, Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria, Urol. Res., 34, 12, 10.1007/s00240-005-0004-6

Ogi, 2006, The oxalate level in ultrafiltrate fluid collected from a dialyzer is useful for estimating the plasma oxalate level in hemodialysis patients, Clin. Exp. Nephrol., 10, 118, 10.1007/s10157-006-0406-y

Marangella, M., Cosseddu, D., Petrarulo, M., Vitale, C., and Linari, F. (1993). Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria. Nephrol. Dial. Transplant.

Tubben, A., Sotomayor, C.G., Post, A., Minovic, I., Frelink, T., de Borst, M.H., Said, M.Y., Douwes, R.M., van den Berg, E., and Rodrigo, R. (2019). Urinary oxalate excretion and long-term outcomes in kidney transplant recipients. J. Clin. Med., 8.

Pinheiro, 2005, Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival, Am. J. Transplant., 5, 323, 10.1111/j.1600-6143.2004.00684.x

Bagnasco, 2008, Oxalate deposits in biopsies from native and transplanted kidneys, and impact on graft function, Nephrol. Dial. Transplant., 24, 1319, 10.1093/ndt/gfn697

Palsson, 2020, The association of calcium oxalate deposition in kidney allografts with graft and patient survival, Nephrol. Dial. Transplant., 35, 888, 10.1093/ndt/gfy271

Taheri, 2015, Acute oxalate nephropathy following kidney transplantation: Report of three cases, J. Res. Med. Sci., 20, 818, 10.4103/1735-1995.168408

Salyer, 1973, Oxalosis as a complication of chronic renal failure, Kidney Int., 4, 61, 10.1038/ki.1973.80

Elgstoen, 2010, Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria, Nephrol. Dial. Transplant., 25, 2341, 10.1093/ndt/gfq065

Worcester, 1994, Effect of renal transplantation on serum oxalate and urinary oxalate excretion, Nephron, 67, 414, 10.1159/000188014

Roberts, 2008, Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: Was mycophenolate the cause?, Nephrol. Dial. Transplant., 23, 2409, 10.1093/ndt/gfn194